News

Company is broadening its monitoring services to include devices, nutritional supplements and 'designer drugs'

Study of technical readability, and a trial of potential patients, show little progress in improving patient understanding

Latest global survey of life expectancy shows steady increases for most of the world since 2000

Peer-reviewed study correlates adverse drug events (ADEs) with form of drug administration; can pharma manufacturers help?

A $1-billion private/public partnership reaches fruition - with implications for vaccine supply chains

Annual publication polls manufacturers and distributors on temperature-controlled shipping practices

Lab is one of the early adopters of the voluntary College of American Pathologists accreditation

Abbott's long-scheduled splitup creates two giants

Annual Gallup poll shows a slightly rising ranking for most professions

Physicians continue to decline as the target customer base for industry marketing, according to survey repondents

Broad-based print and digital publisher will tailor service to specific health conditions

New testing shows the effectiveness of blankets in long-distance shipments; FedEx touts the value of its Boeing 777F fleet with controlled environments

New testing shows the effectiveness of blankets in long-distance shipments; FedEx touts the value of its Boeing 777F fleet with controlled environments

New study magnifies the lost opportunity for industry sixfold; the global gap is $564 billion

More doctors are expected to be charged; meanwhile, California e-pedigree meetings restart

WHO meeting bans nongovernmental organizations (NGOs) who advocate for more-comprehensive treaties

Life sciences runners-up include executives of Spectrum Pharmaceuticals, Dohmen Group and Gauthier Biomedical

PBM-sponsored program passes on its discounts from manufacturers

Companies were served subpoenas dating back to 2007

HDMA seminar attendees are skeptical of the project rising sufficiently on Congress' calendars

Cold chain products constitute 10% of SKUs, on average

Maybe not, as biotech companies develop on-the-spot treatments

CVS Caremark updates its list of blocked drugs that will not be available on its formularies, in part to battle manufacturers’ copay programs

CVS Caremark updates its list of blocked drugs that will not be available on its formularies, in part to battle manufacturers' copay programs

While the "fiscal cliff" looms over all legislative activity, Congress' agenda for FDA and healthcare is already setting up, says Patton Boggs

New report assesses the progress in adopting both of these marketing techniques

Next-gen SenseAware 2000 is deployed, along with a wider international distribution

Valley had $130 million in 2011 revenue